Please note this is an extract of the original bulletin.
Page summary:
The government will streamline the system to modernise regulatory legislation to boost patient safety and support staff
Change made:
First published.
Lord O’Shaughnessy to lead independent review into UK clinical trials
Page summary:
Lord James O’Shaughnessy has been appointed to conduct an independent review into the UK commercial clinical trials landscape.
Change made:
First published.
Pathogen inactivation technologies for platelets: SaBTO advice
Page summary:
Recommendations from the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) for maintaining the safety of platelets.
Change made:
First published.
SaBTO reports and guidance documents
Page summary:
Reports published by the advisory committee on the Safety of Blood, Tissues and Organs (SaBTO).
Change made:
Added ‘Pathogen inactivation technologies for platelets: SaBTO advice’ to the guidance reports.
